Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption.
The present study was designed to test the hypothesis that estrogen receptors (ER) in the blood vessel wall play a role in the modulation of the release of endothelium-derived nitric oxide (EDNO). Both basal and stimulated release of EDNO were determined in aortic rings isolated from female and male wild-type and male homozygous estrogen receptor knock-out (ERKO) mice. 125I-17beta-estradiol binding in aortic tissue showed significantly more high affinity cytosolic- nuclear-binding sites in male compared with female wildtype mice. Estrogen receptor transcripts were present in the aorta of male wild-type mice, but they were absent in male ERKO animals. Basal release of EDNO (determined by endothelium-dependent contraction caused by NG-nitro-arginine) was significantly higher in aorta of wild-type male mice compared with wild-type female mice, and significantly lower in the aorta of male ERKO compared with male wild-type mice. Acetylcholine-induced endothelium-dependent relaxation was similar in all groups studied. No difference was observed in the activity of calcium-dependent nitric oxide synthase in homogenates of lungs and brain taken from male wild-type and ERKO mice. These studies show a significant association between the number of estrogen receptors and basal release of EDNO in the aorta of mice, and suggest that decreased vascular estrogen receptor number may represent a novel risk factor for cardiovascular diseases.
Rubanyi
G M
GM
Department of Cardiovascular Research, Berlex Biosciences, Richmond, California 94804-0099, USA. gabor_rubanyi@berlex.com
Freay
A D
AD
Kauser
K
K
Sukovich
D
D
Burton
G
G
Lubahn
D B
DB
Couse
J F
JF
Curtis
S W
SW
Korach
K S
KS
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D000818:Animals; D001011:Aorta / Q000502:physiology; D001921:Brain / Q000201:enzymology; D017931:DNA Primers; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology*; D004790:Enzyme Induction; D004958:Estradiol / Q000097:blood; D005091:Exons; D005260:Female; D066298:In Vitro Techniques; D008168:Lung / Q000201:enzymology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology*; D009569:Nitric Oxide / Q000096:biosynthesis*; D019001:Nitric Oxide Synthase / Q000096:biosynthesis*; D019335:Nitroarginine / Q000494:pharmacology*; D016133:Polymerase Chain Reaction; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology; D011960:Receptors, Estrogen / Q000096:biosynthesis* / Q000235:genetics; D012727:Sex Characteristics; D013045:Species Specificity; D013928:Thromboxane A2 / Q000031:analogs & derivatives / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D017931:DNA Primers; D011450:Prostaglandin Endoperoxides, Synthetic; D011960:Receptors, Estrogen; D014662:Vasoconstrictor Agents; D019335:Nitroarginine; D009569:Nitric Oxide; D004958:Estradiol; D013928:Thromboxane A2; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D019001:Nitric Oxide Synthase